Literature DB >> 21882820

Small molecule receptor protein tyrosine phosphatase γ (RPTPγ) ligands that inhibit phosphatase activity via perturbation of the tryptophan-proline-aspartate (WPD) loop.

Steven Sheriff1, Brett R Beno, Weixu Zhai, Walter A Kostich, Patricia A McDonnell, Kevin Kish, Valentina Goldfarb, Mian Gao, Susan E Kiefer, Joseph Yanchunas, Yanling Huang, Shuhao Shi, Shirong Zhu, Carolyn Dzierba, Joanne Bronson, John E Macor, Kingsley K Appiah, Ryan S Westphal, Jonathan O'Connell, Samuel W Gerritz.   

Abstract

Protein tyrosine phosphatases (PTPs) catalyze the dephosphorylation of tyrosine residues, a process that involves a conserved tryptophan-proline-aspartate (WPD) loop in catalysis. In previously determined structures of PTPs, the WPD-loop has been observed in either an "open" conformation or a "closed" conformation. In the current work, X-ray structures of the catalytic domain of receptor-like protein tyrosine phosphatase γ (RPTPγ) revealed a ligand-induced "superopen" conformation not previously reported for PTPs. In the superopen conformation, the ligand acts as an apparent competitive inhibitor and binds in a small hydrophobic pocket adjacent to, but distinct from, the active site. In the open and closed WPD-loop conformations of RPTPγ, the side chain of Trp1026 partially occupies this pocket. In the superopen conformation, Trp1026 is displaced allowing a 3,4-dichlorobenzyl substituent to occupy this site. The bound ligand prevents closure of the WPD-loop over the active site and disrupts the catalytic cycle of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21882820     DOI: 10.1021/jm2003766

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

Review 1.  Small molecule tools for functional interrogation of protein tyrosine phosphatases.

Authors:  Rongjun He; Li-Fan Zeng; Yantao He; Sheng Zhang; Zhong-Yin Zhang
Journal:  FEBS J       Date:  2012-08-16       Impact factor: 5.542

2.  Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders.

Authors:  Miryam Pastor; Rosalía Fernández-Calle; Bruno Di Geronimo; Marta Vicente-Rodríguez; José María Zapico; Esther Gramage; Claire Coderch; Carmen Pérez-García; Amy W Lasek; Leonor Puchades-Carrasco; Antonio Pineda-Lucena; Beatriz de Pascual-Teresa; Gonzalo Herradón; Ana Ramos
Journal:  Eur J Med Chem       Date:  2017-11-28       Impact factor: 6.514

3.  Computational Strategy for Bound State Structure Prediction in Structure-Based Virtual Screening: A Case Study of Protein Tyrosine Phosphatase Receptor Type O Inhibitors.

Authors:  Xuben Hou; David Rooklin; Duxiao Yang; Xiao Liang; Kangshuai Li; Jianing Lu; Cheng Wang; Peng Xiao; Yingkai Zhang; Jin-Peng Sun; Hao Fang
Journal:  J Chem Inf Model       Date:  2018-10-19       Impact factor: 4.956

4.  Characterization of PTPRG in knockdown and phosphatase-inactive mutant mice and substrate trapping analysis of PTPRG in mammalian cells.

Authors:  Wandong Zhang; Katerina V Savelieva; David T Tran; Vladimir M Pogorelov; Emily B Cullinan; Kevin B Baker; Kenneth A Platt; Sean Hu; Indrani Rajan; Nianhua Xu; Thomas H Lanthorn
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

5.  Targeting PTPRZ inhibits stem cell-like properties and tumorigenicity in glioblastoma cells.

Authors:  Akihiro Fujikawa; Hajime Sugawara; Taisaku Tanaka; Masahito Matsumoto; Kazuya Kuboyama; Ryoko Suzuki; Naomi Tanga; Atsuto Ogata; Makoto Masumura; Masaharu Noda
Journal:  Sci Rep       Date:  2017-07-17       Impact factor: 4.379

6.  A New Paradigm for KIM-PTP Drug Discovery: Identification of Allosteric Sites with Potential for Selective Inhibition Using Virtual Screening and LEI Analysis.

Authors:  James Adams; Benjamin P Thornton; Lydia Tabernero
Journal:  Int J Mol Sci       Date:  2021-11-11       Impact factor: 5.923

7.  Regulative Loop between β-catenin and Protein Tyrosine Receptor Type γ in Chronic Myeloid Leukemia.

Authors:  Luisa Tomasello; Marzia Vezzalini; Christian Boni; Massimiliano Bonifacio; Luigi Scaffidi; Mohamed Yassin; Nader Al-Dewik; Paul Takam Kamga; Mauro Krampera; Claudio Sorio
Journal:  Int J Mol Sci       Date:  2020-03-26       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.